Ajay Ahuja, MD, MBA, CEO, Nexus

Dr Ajay Ahuja, CEO of Nexus, is an accomplished executive with over 20 years of experience leading global business initiatives across industries, ranging from developmental-stage companies to Fortune 100 corporations.  The Nexus Embassy is an innovative high-tech company pioneering the most advanced blockchain technology, providing strategic direction and leadership to drive the rapid expansion of this transformational technology, enabling revolutionary applications across many industries including Health Care.

Immediately prior to Nexus, Dr Ahuja was a the Global Head of Medical Affairs at the multinational pharmaceutical company Allergan, accountable for all such activities for every drug in every country.  Before that, at Pfizer and Takeda Pharmaceuticals, he utilized medical R&D leadership roles to drive for results in drug development clinical trials and new product launches, while also enabling to transform the departments through multiple initiatives, including leading innovations for the coordinated development of commercial, medical and R&D strategies

Earlier in his career, Dr Ahuja progressed through critical US and Global roles in Marketing, Strategy, Commercial Operations, and Business Development with the Swiss-based pharma giant Novartis, and Tepha, a biotech start-up, achieving immense success in the markets while developing productive internal and external relationships.

After receiving a Bachelors degree from Duke University, Ajay earned his MD degree from WashU and trained in Cardiology at Harvard.  He then earned an MBA from Harvard Business School.

Dr Ahuja has dual citizenship in the U.S. and U.K., and he speaks four languages.